ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02297698
Brief Title: Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients (HER3+)

First Submitted : November 14, 2014
First Submitted that Met QC Criteria : November 19, 2014
First Posted : November 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : December 12, 2018
Last Update Posted : December 14, 2018